Clinical Trial Update: Nintedanib for Improving Reproductive Outcomes in Adenomyosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nintedanib for improving reproductive outcomes in patients with adenomyosis has been announced; the study is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis

Drugs mentioned

• Nintedanib (Ofev) (Nintedanib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Adenomyosis of Uterus | Phase 3 | Status: NOT_YET_RECRUITING